Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How the Intussusception Market Has Progressed: A Look Back Over the Past Few Years?
The market size for intussusception has seen a consistent increase over the past few years. It is projected to expand from $4.45 billion in 2024 to $4.67 billion in 2025, at a compound annual growth rate (CAGR) of 4.8%.
The growth observed in the historical period is due to several factors, including enhanced diagnostic tools, growth in public awareness and education, expansion in global healthcare infrastructure, increased investments in research and development, and collaboration amongst healthcare organizations.
In the coming years, the intussusception market is set to experience consistent growth, with an expected valuation of $5.46 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.0%. The projected rise during these years could be a result of continued efforts in medical education, child vaccination initiatives, worldwide actions towards child healthcare, an emphasis on care after operations, increasing need for research in the field of child gastrointestinal disorders, and wider access to telehealth.
Key trends for this upcoming period in the market include evolution in diagnostic imaging, application of less invasive treatments, creation of interventions specifically designed for children, in-depth study on causes and risk factors, worldwide disease surveillance studies, introduction of vaccination programmes, and the use of telehealth for both diagnosis and advice.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Are the Key Drivers Fueling Growth in the Intussusception Market?
The upward trend in intestinal disorders is predicted to drive the intussusception market’s expansion. Intestinal disorders, which affect the proper operation of the intestines – a critical part of the body’s digestive system responsible for nutrient absorption and waste removal – are a significant concern.
The growing prevalence of such disorders, including inflammatory bowel disease and gastrointestinal cancers, can result in earlier detection, better treatment alternatives, and improved support for people suffering from intussusception, ultimately enhancing their health and quality of life. For example, in January 2023, the American Cancer Society (ACS), a US-based health organization committed to cancer eradication, reported a 3.18% rise in gastrointestinal cancers to 348,840, up from 338,090 in 2021 in the United States.
Consequently, the escalating prevalence of intestinal disorders will stimulate the progression of the intussusception market.
Which Key Segments Are Driving Growth in the Intussusception Market?
The intussusceptionmarket covered in this report is segmented –
1) By Type: Idiopathic Intussusception; Secondary Intussusception
2) By Treatment: Enema Reduction; Surgery; Other Treatment
3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)
4) By End-User: Hospitals; Clinics; Other End-User
Subsegments:
1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception; Adult Idiopathic Intussusception
2) By Secondary Intussusception: Neoplastic Intussusception; Infectious Intussusception; Inflammatory Intussusception; Post-Surgical Intussusception
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Emerging Trends Will Impact the Intussusception Market in the Forecast Period?
Leading businesses in the intestinal pseudo-obstruction treatment market are focusing on the creation of groundbreaking drug therapies, such as NHE3 inhibitor treatment therapy, to ensure dependable services to their clients. The NHE3 inhibitor treatment therapy is a drug that functions by suppressing the Sodium-Proton-Exchanger subtype 3 (NHE3) in the intestine.
For example, Ardelyx Inc., a biopharmaceutical company based in the U.S., launched in April 2022, a treatment for irritable bowel syndrome with constipation (IBS-C) in adults, IBSRELA, which is an NHE3 inhibitor, enhancing gastrointestinal mobility. IBSRELA operates by restricting the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein.
The treatment was endorsed based on two Phase 3 trials involving more than 1,200 IBS-C patients, showing substantial improvement in abdominal pain and bowel movement, hitting the primary goal, exhibiting improvements as early as the first week, and continuing for 26 weeks in the long-term trial.
Which Geographies Are Leading the Expansion of the Intussusception Market?
North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Intussusception Market in 2025?
Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co.
KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=13466
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
